Abstract: Embodiments of this application provide a target detection method and apparatus, an electronic device, and a computer storage medium. The method includes: obtaining a target image including a target object; performing instance segmentation on the target image, to obtain a segmentation mask corresponding to the target object; obtaining, based on the segmentation mask, position relationship features between target pixels in a target region in which the target object is located in the target image; obtaining position relationship features between standard pixels in a preset region of interest in a standard image, where the standard image includes a standard object corresponding to the target object; and matching the position relationship features between the target pixels and the position relationship features between the standard pixels, to obtain a correspondence between the target pixels and the standard pixels, and obtaining pose information of the target object based on the correspondence.

Abstract: The present invention provides methods of treating a subject having a primary inflammatory disease or disorder comprising administering to the subject a composition comprising a conjugate of an LLP2A peptidomimetic ligand and a bisphosphonate drug, wherein the composition comprising the LLP2A-bisphosphonate conjugate enhances the delivery of mesenchymal stem cells to a site of inflammation. Methods of enhancing an anti-inflammatory or immunomodulatory property of mesenchymal stem cells, comprising administering to a subject in need thereof the mesenchymal stem cells and a composition comprising a conjugate of an LLP2A peptidomimetic ligand and a bisphosphonate drug, are also provided.

Abstract: This invention relates to a curable adhesive composition. In particular, the present invention relates to a curable adhesive composition for die attach, which eliminates the void issue, minimizes the fillet, and has lower bond line thickness and tilt trend, when cured.

Abstract: A connector includes an insulation shell, a pair of contact terminals, and a pair of connection terminals. The insulation shell has a front mating port and a rear opening, a pair of side openings, and two receiving chambers. The pair of contact terminals are each installed into one of two receiving chambers of the insulation shell and each have a front contact part and a side contact part. The pair of connection terminals are each inserted into one of the pair of side openings and each mate with one side contact part. Each front contact part is in the front mating port and electrically contacts a mating plug of a mating connector inserted into the front mating port. A part of each connection terminal is exposed from one side opening for electrical connection to an electrical connecting member.

Abstract: Methods of treating osteonecrosis in a subject are provided. In some embodiments, the method comprises administering to a subject having or suspected of having osteonecrosis a pharmaceutical composition comprising a conjugate of an LLP2A peptidomimetic ligand and a bisphosphonate drug. In some embodiments, the pharmaceutical composition comprises a conjugate of LLP2A and alendronate (LLP2A-Ale). In some embodiments, the method further comprises administering exogenous mesenchymal stem cells.

Abstract: A friction test device based on a torsional Hopkinson bar (THB) includes a base, a baffle, and pull rods. The servo axial loading device includes a first oil pressure tank and a first pressure rod. One end of the first pressure rod is embedded in the first oil pressure tank. The baffle includes a front baffle and a rear baffle. The pull rods are arranged between the front baffle and the rear baffle. A loading guide rod is provided between the front baffle and the rear baffle. The rear baffle is fixed thereon with a constraint mass. The loading guide rod includes one end connected to the first pressure rod and the other end connected to the constraint mass through a specimen. The friction test device further includes a torque application device and a torque storage device. Therefore, the specimen undergoes a full friction process from static to dynamic.

Abstract: A power connector system includes a circuit card assembly having a circuit board with a mounting area, power conductors at the mounting area, and signal conductors at the mounting area. A board power connector includes a board housing with a cavity open at the front and a bottom mounted to the circuit board of the circuit card assembly at the mounting area. The board power connector includes board power contacts held by the board housing and received in the cavity. The power connector system includes a cable power connector mated to the board power connector with a cable housing holding cable power contacts terminated to corresponding power cables and mated to the board power contacts and holding cable signal contacts mated with the signal conductors of the circuit board.

Abstract: The present disclosure provides a compound weeding composition for a sugarcane field. Active ingredients of the weeding composition are mesotrione, ametryn, and fluroxypyr-meptyl, and a weight ratio of the mesotrione to the ametryn to the fluroxypyr-meptyl is 1-50:1-70:1-50.

Abstract: In an aspect, an apparatus may include a lid and a package substrate. The package substrate may include a first metallization structure on a substrate core and an embedded lid support structure disposed on a perimeter of the first metallization structure in the package substrate. The lid is coupled to the substrate core through the embedded lid support structure.

Abstract: An electronic assembly for installing electronic devices includes a housing, an intermediate plate, an inlet pipe, an outlet pipe, and a plurality of lead-wires. The housing has a wall portion which circumscribes and defines a hollowed chamber. The intermediate plate is provided within the chamber and is fixed to the wall portion, with the electronic devices being fixed to and electrically coupled with the intermediate plate. The inlet pipe and the outlet pipe are respectively formed to penetrate the wall portion and configured to introduce a coolant into the chamber and discharge the coolant from the chamber. At least one of the electronic devices and the intermediate plate is electrically coupled to an exterior of the housing through the plurality of lead-wires. Each electronic device is in a sealed package form and immersed in the coolant.

Abstract: A counterweight for an elevator system and an elevator system. The elevator system includes an elevator car and a counterweight connected to each other through a rope; the counterweight includes a counterweight frame and a plurality of counterweight blocks mounted on the counterweight frame, the counterweight frame includes a first main surface and a second main surface opposite to each other, the counterweight blocks are arranged between the first main surface and the second main surface; a first inverted arch beam and a second inverted arch beam connected to the first main surface and the second main surface respectively; and a load-bearing shaft connected between the first inverted arch beam and the second inverted arch beam; the counterweight is connected to the rope through the load-bearing shaft.

Abstract: An electrical connection assembly includes an outer conductive shell and an inner conductive body. The outer conductive shell has an annular wall with an upper periphery and a lower periphery axially opposite each other, an elastic part connected to the upper periphery, and a connection part connected to the lower periphery. The inner conductive body is installed in the outer conductive shell and is axially clamped between the elastic part and the connection part. An outer diameter of the inner conductive body is smaller than an inner diameter of the outer conductive shell. The inner conductive body floats axially and radially relative to the outer conductive shell and maintains electrical contact with the outer conductive shell.

Abstract: The invention relates to particular substituted heterocycle fused gamma-carbolines, their prodrugs, in free, solid, pharmaceutically acceptable salt and/or substantially pure form as described herein, pharmaceutical compositions thereof, and methods of use in the treatment of diseases involving the 5-HT2A receptor, the serotonin transporter (SERT), pathways involving the dopamine D1 and D2 receptor signaling system, and/or the ?-opioid receptor.

Abstract: The provided is a test system and method for achieving three-directional multiphase seepage in a true triaxial loading process. The test system includes a three-directional multiphase seepage loading cabin including a sample metal frame, a loading frame, an outer plate, a fluid injection module, a fluid recovery module, and six loading indenter modules as well as a fluid injection and measurement system; the sample metal frame is arranged at a center of the loading frame, the outer plate is arranged on the loading frame, the fluid injection module and the fluid recovery module are arranged respectively at an upper part and a lower part of the loading frame, and the fluid injection and measurement system is connected to the three-directional multiphase seepage loading cabin; and the loading indenter modules are arranged in the loading frame from six directions, and the indenters of the loading indenter modules are arranged.

Abstract: A dynamic friction experimental device includes a base, an incident bar, an axial compression device, and a torque loading device. The base is provided with a displacement-constrain structure, and the incident bar includes a first incident section and a second incident section. The first incident section is arranged adjacent to the displacement-constrain structure, and the second incident section is connected to the first incident section. At a joint of the first incident section and the second incident section, a projection of a cross section of the first incident section is positioned in a cross section of the second incident section along an axial direction of the second incident section. When the dynamic mechanical property of a specimen is tested, the axial compression device is configured to apply pressure to the second incident section, and the torque loading device is configured to apply torque to the second incident section.

Abstract: The disclosure provides new transmucosal and subcutaneous pharmaceutical compositions comprising 1-(4-fluoro-phenyl)-4-((6bR,10aS)-3-methyl-2,3,6b,9,10,10a-hexahydro-1H,7H-pyrido[3?,4?:4,5]pyrrolo[1,2,3-de]quinoxalin-8-yl)-butan-1-one or 1-(4-fluoro-phenyl)-4-((6bR,10aS)-2,2-d2-3-methyl-2,3,6b,9,10,10a-hexahydro-1H,7H-pyrido[3?,4?:4,5]pyrrolo[1,2,3-de]quinoxalin-8-yl)-butan-1-one or comprising-(4-fluoro-phenyl)-4-((6bR,10aS)-1,1,2,2-d4-3-methyl-2,3,6b,9,10,10a-hexahydro-1H,7H-pyrido[3?,4?:4,5]pyrrolo[1,2,3-de]quinoxalin-8-yl)-butan-1-one, in free base, co-crystal or salt form, together with methods of making and using them.

Abstract: The present invention relates to the field of low-voltage electric appliances, in particular to an operating mechanism and a switching device including the operating mechanism. When the operating mechanism is opened, an operating shaft drives an energy storage turntable and a transmission plate at the same time. The transmission plate moves from a transmission plate closing position to a transmission plate breaking position. The energy storage turntable drives an output shaft structure to rotate from an output shaft closing position to an output shaft breaking position. After a first spring begins to release energy, the energy storage turntable drives the output shaft structure to rotate to a breaking transition position and is disengaged from the output shaft structure after driving the output shaft structure to cross over the breaking transition position.

Abstract: This invention relates to a conductive epoxy resin composition, in particular for bonding copper substrate, and the cured product, and the use thereof as well as a semiconductor device comprising the cured product.

Abstract: The disclosure provides new transmucosal and subcutaneous pharmaceutical compositions comprising 1-(4-fluoro-phenyl)-4-((6bR,10aS)-3-methyl-2,3,6b,9,10,10a-hexahydro-1H,7H-pyrido[3?,4?:4,5]pyrrolo[1,2,3-de]quinoxalin-8-yl)-butan-1-one or 1-(4-fluoro-phenyl)-4-((6bR,10aS)-2,2-d2-3-methyl-2,3,6b,9,10,10a-hexahydro-1H,7H-pyrido[3?,4?:4,5]pyrrolo[1,2,3-de]quinoxalin-8-yl)-butan-1-one or comprising -(4-fluoro-phenyl)-4-((6bR,10aS)-1,1,2,2-d4-3-methyl-2,3,6b,9,10,10a-hexahydro-1H,7H-pyrido[3?,4?:4,5]pyrrolo[1,2,3-de]quinoxalin-8-yl)-butan-1-one, in free base, co-crystal or salt form, together with methods of making and using them.